Add to ORKGHMG Co-A reductase inhibitors (statins) are effective for primary prevention of ischemic stroke in people who have a history of occlusive artery disease, coronary artery disease, or diabetes without history of cerebrovascular disease (strength of recommendation [SOR]: A, based on 1 randomized controlled trial [RCT]). Statins reduce the risk of ischemic stroke in hypertensive patients with multiple cardiovascular risk factors and nonfasting total cholesterol <250 mg/dL (SOR: A, based on RCT). Statins also reduce the risk of ischemic stroke for patients with coronary disease or equivalents (such as diabetes or peripheral artery disease), including patients who have a normal fasting lipid profile (SOR: A, based on RCT). For patients with ische...
Elevated low-density lipoprotein-cholesterol (LDL-C) is a causal factor for the development of ather...
Randomized trials with statins have shown a modest but significant absolute reduction in the inciden...
Atherosclerotic plaques can form in the blood vessels from particles of cholesterol. These plaques a...
Statin therapy has become one of the most widely prescribed medications in the world because of its ...
Stroke is a frequently encountered clinical event that has a detrimental impact on the quality of li...
An association between hypercholesterolaemia and ischaemic stroke has not yet been clearly defined b...
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (also known as statins) are dru...
Background: Statins may prevent recurrent ischemic events after ischemic stroke. Determining which s...
BACKGROUND Statins may prevent recurrent ischemic events after ischemic stroke. Determining which...
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (also known as statins) are dru...
Introduction Stroke is a major public health problem. It is the third leading cause of death worl...
Atherosclerosis is a systemic process, and the leading cause of morbidity and mortality in the devel...
PURPOSE: More than 120,000 patients now have taken part in randomized trials evaluating statin thera...
An important issue for stroke prevention is the identification and treatment of risk factors such as...
The link between serum cholesterol levels and the incidence of stroke still remain to be established...
Elevated low-density lipoprotein-cholesterol (LDL-C) is a causal factor for the development of ather...
Randomized trials with statins have shown a modest but significant absolute reduction in the inciden...
Atherosclerotic plaques can form in the blood vessels from particles of cholesterol. These plaques a...
Statin therapy has become one of the most widely prescribed medications in the world because of its ...
Stroke is a frequently encountered clinical event that has a detrimental impact on the quality of li...
An association between hypercholesterolaemia and ischaemic stroke has not yet been clearly defined b...
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (also known as statins) are dru...
Background: Statins may prevent recurrent ischemic events after ischemic stroke. Determining which s...
BACKGROUND Statins may prevent recurrent ischemic events after ischemic stroke. Determining which...
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (also known as statins) are dru...
Introduction Stroke is a major public health problem. It is the third leading cause of death worl...
Atherosclerosis is a systemic process, and the leading cause of morbidity and mortality in the devel...
PURPOSE: More than 120,000 patients now have taken part in randomized trials evaluating statin thera...
An important issue for stroke prevention is the identification and treatment of risk factors such as...
The link between serum cholesterol levels and the incidence of stroke still remain to be established...
Elevated low-density lipoprotein-cholesterol (LDL-C) is a causal factor for the development of ather...
Randomized trials with statins have shown a modest but significant absolute reduction in the inciden...
Atherosclerotic plaques can form in the blood vessels from particles of cholesterol. These plaques a...